These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35456593)

  • 1. Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations.
    Miyamoto K; Akita T; Yamashita C
    Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple Method to Measure the Aerodynamic Size Distribution of Porous Particles Generated on Lyophilizate for Dry Powder Inhalation.
    Miyamoto K; Taga H; Akita T; Yamashita C
    Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33076510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma scintigraphic evaluation of a novel budesonide dry powder inhaler using a validated radiolabeling technique.
    Warren S; Taylor G; Smith J; Buck H; Parry-Billings M
    J Aerosol Med; 2002; 15(1):15-25. PubMed ID: 12006142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of radiolabeling of drug formulations for aerosol deposition assessment of orally inhaled products.
    Devadason SG; Chan HK; Haeussermann S; Kietzig C; Kuehl PJ; Newman S; Sommerer K; Taylor G
    J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25 Suppl 1():S6-9. PubMed ID: 23215848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalable liposomes of Glycyrrhiza glabra extract for use in tuberculosis: formulation, in vitro characterization, in vivo lung deposition, and in vivo pharmacodynamic studies.
    Viswanathan V; Pharande R; Bannalikar A; Gupta P; Gupta U; Mukne A
    Drug Dev Ind Pharm; 2019 Jan; 45(1):11-20. PubMed ID: 30122088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of Very Low-Dose Formulation of Vitamin D3 with Lyophilizate for Dry Powder Inhalation System by Simple Method Based on Time-of-Flight Theory.
    Miyamoto K; Yanagisawa M; Taga H; Yamaji H; Akita T; Yamashita C
    Pharmaceutics; 2021 Apr; 13(5):. PubMed ID: 33946783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Delivery of hGhrelin Derivative by Lyophilizate for Dry Powder Inhalation System in Monkeys.
    Miyamoto K; Ishibashi Y; Akita T; Yamashita C
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33562278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary and Regional Deposition of Nebulized and Dry Powder Aerosols in Ferrets.
    Kuehl PJ; Chand R; McDonald JD; Hava DL; DeHaan WH
    AAPS PharmSciTech; 2019 Jul; 20(6):242. PubMed ID: 31264190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of device resistance and inhalation flow rate on the lung deposition of orally inhaled mannitol dry powder.
    Yang MY; Verschuer J; Shi Y; Song Y; Katsifis A; Eberl S; Wong K; Brannan JD; Cai W; Finlay WH; Chan HK
    Int J Pharm; 2016 Nov; 513(1-2):294-301. PubMed ID: 27639621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constrictive conditions.
    Bhavna ; Ahmad FJ; Mittal G; Jain GK; Malhotra G; Khar RK; Bhatnagar A
    Eur J Pharm Biopharm; 2009 Feb; 71(2):282-91. PubMed ID: 18984050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung Deposition of the Dry Powder Fixed Combination Beclometasone Dipropionate Plus Formoterol Fumarate Using NEXThaler
    Virchow JC; Poli G; Herpich C; Kietzig C; Ehlich H; Braeutigam D; Sommerer K; Häussermann S; Mariotti F
    J Aerosol Med Pulm Drug Deliv; 2018 Oct; 31(5):269-280. PubMed ID: 29989511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do inhaled carbon nanoparticles translocate directly into the circulation in humans?
    Mills NL; Amin N; Robinson SD; Anand A; Davies J; Patel D; de la Fuente JM; Cassee FR; Boon NA; Macnee W; Millar AM; Donaldson K; Newby DE
    Am J Respir Crit Care Med; 2006 Feb; 173(4):426-31. PubMed ID: 16339922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of LDPI to SPECT perfusion imaging using (99m)Tc-sestamibi and (99m)Tc-pyrophosphate in a murine ischemic hind limb model of neovascularization.
    Hendrikx G; Vries MH; Bauwens M; De Saint-Hubert M; Wagenaar A; Guillaume J; Boonen L; Post MJ; Mottaghy FM
    EJNMMI Res; 2016 Dec; 6(1):44. PubMed ID: 27234510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabeling of Preformed Niosomes with [
    Almasi A; Shahhosseini S; Haeri A; Daha FJ; Geramifar P; Dadashzadeh S
    AAPS PharmSciTech; 2018 Nov; 19(8):3859-3870. PubMed ID: 30291544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers.
    Newhouse MT; Hirst PH; Duddu SP; Walter YH; Tarara TE; Clark AR; Weers JG
    Chest; 2003 Jul; 124(1):360-6. PubMed ID: 12853545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (99m)Tc-labeled therapeutic inhaled amikacin loaded liposomes.
    Lee JH; Cheng KT; Malinin V; Li Z; Yao Z; Lee SJ; Gould CM; Olivier KN; Chen C; Perkins WR; Paik CH
    J Liposome Res; 2013 Dec; 23(4):336-42. PubMed ID: 23879241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers.
    Glover W; Chan HK; Eberl S; Daviskas E; Verschuer J
    Int J Pharm; 2008 Feb; 349(1-2):314-22. PubMed ID: 17904774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Numerical simulation of the effect of inhalation parameters, gender, age and disease severity on the lung deposition of dry powder aerosol drugs emitted by Turbuhaler®, Breezhaler® and Genuair® in COPD patients.
    Horváth A; Farkas Á; Szipőcs A; Tomisa G; Szalai Z; Gálffy G
    Eur J Pharm Sci; 2020 Nov; 154():105508. PubMed ID: 32836137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery.
    Liu S; Watts AB; Du J; Bui A; Hengsawas S; Peters JI; Williams RO
    Eur J Pharm Biopharm; 2015 Oct; 96():132-42. PubMed ID: 26220015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient optimization of high-dose formulation of novel lyophilizates for dry powder inhalation by the combination of response surface methodology and time-of-flight measurement.
    Ohori R; Kiuchi S; Sugiyama S; Miyamoto K; Akita T; Yamashita C
    Int J Pharm; 2020 May; 581():119255. PubMed ID: 32217154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.